Combined Phacoaspiration and Angle Surgery Versus Phacoaspiration in Pediatric Cataract

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-30

Study Completion Date

2023-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to report the effectiveness of phacoaspiration when combined with angle surgery in preventing postoperative glaucoma following pediatric cataract surgery

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Stepped Surgery in Uveitic Cataract: A Novel Approach to a Quiet Eye

NCT04931277

Outcome of Stepped Cataract Surgery in Uveitis

COMPLETED NA

Evaluation of Intraoperative Lagophthalmos Formula

NCT04291625

Ptosis, Eyelid

COMPLETED NA

Phaco-UCP Versus Phaco Alone for OAG and Cataract

NCT04430647

Cataract Glaucoma, Open-Angle

COMPLETED NA

Biometric Characteristics of the Eye With Microcornea/Microphthalmia and Congenital Cataract Before And After Cataract Extraction

NCT04759560

Congenital Cataract Microphthalmos Microcornea

UNKNOWN

Outcome of Capsular After Pediatric Cataract Surgery With Primary Intraocular Lens Implantation

NCT04357249

Pediatric Cataract

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As postoperative glaucoma could be the consequence of a dysgenesis of the iridocorneal angle that accompanies the dysgenesis of the lens so, the hypothesis states that combined phacoaspiration with angle surgery may be superior to phacoaspiration as standalone procedure in controlling IOP within the normal range postoperatively after pediatric cataract surgery

• Patients with pediatric cataract will be subdivided into 2 groups: Group A: includes eyes for whom combined phacoaspiration \& angle surgery will be done.

Group B: includes eyes for whom phacoaspiration only will be done. All surgeries will be performed in Mansoura Ophthalmic Center by the same surgeon or under his supervision.

Preoperative:

1. History: Full ocular \& general history will be taken Ocular history: history of ocular trauma, ocular surgeries \& wearing glasses. General medical history: age, history of any associated neurologic, metabolic or systemic disease or drug intake.
2. Examination: Full ocular examination will be done

* Anterior segment examination using (Topcon or Zeiss surgical microscopes) or (Zeiss or hag streit slit lamps).
* Corneal diameter will be measured.
* Fundus examination using indirect ophthalmoscope (KEELER Vantage Plus indirect ophthalmoscope) if the fundus is visible.
* IOP measuring using Schoitz tonometer.
* Refraction (if the eye can be refracted) \& K readings will be measured using portable autorefractometer (Retinomax K-plus2).
3. Investigations:

* Axial length, anterior chamber depth \& Ocular biometry will be measured using (Nidek Al-Scan Optical Biometer).
* B-scan will be done using (Nidek Us-4000 Echoscan).
* Ultrasound biomicroscopy (UBM) scan will be performed using (VuMAX HD).

Intraoperative:

1. Group A: for whom combined phacoaspiration \& angle surgery ither trabeculotomy will be done. I

* Partial thickness scleral flap to access the canal of schlemm.
* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.
* Using metal trabeculotomes to open thetrabecular meshwork after accessing the canal of schlemm.
* Suturing of scleral flap with 10-0 Nylon suture.
2. Group B: for whom phacoaspiration only will be done.

* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.

Postoperative:

1. All patients will be discharged on:

* Systemic \&topical antibiotic eye drops.
* Topical steroids.
* Cycloplegic eye drops.
* Combined antibiotic and steroid eye ointment.
2. Topical Steroids \& cycloplegic eye drops will be gradually withdrawn over a period of 3 months.
3. The eyes will be carefully examined at each follow-up visit (1 week, 2 weeks 1months and 3 months).
4. During each visit:

* Anterior segment examination will be done.
* Measuring of:

* Corneal diameter.
* Cup/disc ratio.
* IOP using Schoitz tonometer.
* Axial length, anterior chamber depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Inclusion criteria:

1. Patients with pediatric congenital cataract Aged less than two years associated with other ocular anomalies which is high risk for developing PCSG as microcornea and aniridia.
2. Patient with pediatric cataract with other eye had post cataract surgery glaucoma

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A: includes eyes for whom combined phacoaspiration & angle surgery will be done.

Group A: for whom combined phacoaspiration \& angle surgery trabeculotomy will be done.

* continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.
* Using metal trabeculotomes to open thetrabecular meshwork after accessing the canal of schlemm.
* Suturing of scleral flap with 10-0 Nylon suture.

Group Type ACTIVE_COMPARATOR

Group A :combined phacoaspiration and angle surgery

Intervention Type PROCEDURE

* Partial thickness scleral flap to access the canal of schlemm.
* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.
* Using metal trabeculotomes to open thetrabecular meshwork after accessing the canal of schlemm.
* Suturing of scleral flap with 10-0 Nylon suture.

Group B : includes eyes with only phacoaspiration will be done

Group B: for whom phacoaspiration only will be done.

* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.

Group Type ACTIVE_COMPARATOR

Group B : phacoaspiration only

Intervention Type PROCEDURE

* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group A :combined phacoaspiration and angle surgery

* Partial thickness scleral flap to access the canal of schlemm.
* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.
* Using metal trabeculotomes to open thetrabecular meshwork after accessing the canal of schlemm.
* Suturing of scleral flap with 10-0 Nylon suture.

Intervention Type PROCEDURE

Group B : phacoaspiration only

* 2 side ports will be fashioned.
* Trypan blue will be injected to aid visualization of the anterior capsule \& continuous curvilinear anterior capsulorhexis of approximately 5.0 mm diameter will be done.
* The nucleus and cortex will be aspirated.
* Posterior capsulrehxis and limited anterior vitrectomy will be done.
* Corneal incisions will be sutured with 10-0 Nylon suture.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pediatric congenital cataract Aged less than two years associated with other ocular anomalies which is high risk for developing glaucoma as microcornea and aniridia.
* pediatric cataract with other eye had post cataract surgery glaucoma